The DESKTOP III Trial with Philipp Harter

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial. Prof. Harter is the director of the Department of Gynecology & Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany, and the chair of the AGO Study Group. Highlights: -Role of surgery for relapsed ovarian cancer is under debate -DESKTOP III has shown a significant benefit regarding PFS and OS by secondary cytoreduction -The data, interpretation and clinical consequences are discussed".